Iodine ¹³¹I human albumin Other names: Iodine 131-I human albumin

Pregnancy Category C

Animal reproduction studies have not been conducted with Iodinated I 131 Albumin Injection. It is also not known whether this agent can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity.

Iodinated I 131 Albumin Injection should be administered to a pregnant woman only if clearly needed.

Ideally, examinations using radiopharmaceuticals, especially those elective in nature, of a woman of childbearing capability should be performed during the first few (approximately 10) days following the onset of menses.

Since iodine 131 is excreted in human milk during lactation, formula feedings should be substituted for breast feedings.

No long-term animal studies have been performed to evaluate carcinogenic potential or whether iodinated I 131 albumin affects fertility in males or females.

Although the immunological properties of albumin human are believed to be virtually unaltered by the iodination process, there is a theoretical possibility that allergic reactions may occur in patients receiving additional doses a number of weeks after an initial dose.